Bausch Health Companies (BHC) Gross Margin (2009 - 2026)
Bausch Health Companies (BHC) posted Gross Margin of 73.6% for Q2 2026, up 3.03% sequentially from 71.43% in Q1 2026, and up 316.0% YoY from 17.69% in Q2 2025.
Bausch Health Companies (BHC) Gross Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Gross Margin for 18 years, with the latest figure at 73.6% in Q2 2026.
- Quarterly Gross Margin rose 316.0% year-over-year to 73.6% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 72.43% (up 108.0% YoY) and the FY2025 annual result came in at 71.27%, down 37.0% from the prior year.
- Gross Margin climbed to 73.6% in Q2 2026 per BHC's latest filing, from 71.43% in the prior quarter.
- Over five years, Gross Margin peaked at 73.6% in Q2 2026 and troughed at 69.77% in Q1 2025.
- A 5-year average of 71.51% and a median of 71.29% in 2026 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2026: Gross Margin plunged 2074 bps in 2022, then soared 316 bps in 2026.
- Over 5 years, Gross Margin stood at 70.86% in 2022, then climbed by 0 bps to 71.14% in 2023, then climbed by 2 bps to 72.22% in 2024, then decreased by 0 bps to 72.0% in 2025, then advanced by 2 bps to 73.6% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 73.6%, 71.43%, and 72.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 73.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.60% |
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | 100.14% |
| Sep 30, 2025 | 99.48% |
| Jun 30, 2025 | 98.70% |
| Mar 31, 2025 | 99.96% |
| Dec 31, 2024 | 102.85% |
| Sep 30, 2024 | 95.50% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 101.25% |
| Sep 30, 2023 | 72.65% |
| Jun 30, 2023 | 70.47% |
| Mar 31, 2023 | 70.58% |
| Dec 31, 2022 | 174.65% |
| Sep 30, 2022 | 71.99% |
| Jun 30, 2022 | 71.12% |
| Mar 31, 2022 | 72.05% |
| Dec 31, 2021 | 123.45% |
| Sep 30, 2021 | 72.81% |